The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Mortality is Not Increased in SARS-CoV-2 Infected Persons With Hepatitis C Virus Infection
Liver Int. 2021 Feb 3. doi: 10.1111/liv.14804. Online ahead of print.
Adeel A Butt12, Peng Yan1, Rashid A Chotani34, Obaid S Shaikh15
Author information
1VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
2Weill Cornell Medical College, New York, NY, USA.
3University of Nebraska Medical Center, Omaha, NE, USA.
4Innovative Emergency Management, Morrisville, NC, USA.
5University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Abstract
Background: Impact of SARS-CoV-2 infection upon hospitalization, intensive care unit (ICU) admissions and mortality in persons with hepatitis C virus (HCV) infection is unknown METHODS: We used the Electronically Retrieved Cohort of HCV infected Veterans (ERCHIVES) database to determine the impact of HCV infection upon the rates of acute care hospitalization, ICU admission and all-cause mortality. We identified Veterans with chronic HCV infection and propensity-score matched controls without HCV in ERCHIVES. We excluded those with HIV or hepatitis B virus coinfection, RESULTS: We identified 975 HCV+ and 975 propensity-score matched HCV- persons with SARS-CoV-2 infection. Mean FIB-4 score (±SD) was higher in those with HCV (1.9±2.1 vs. 1.2±0.9; P<0.0001) and a larger proportion of those with HCV had cirrhosis (8.1% vs. 1.4%; P<0.0001). A larger proportion of HCV+ were hospitalized compared to HCV- (24.0% vs. 18.3%; p=0.002); however, those requiring ICU care and mortality was also similar in both groups (6.6% vs. 6.5%; P=0.9). Among those with FIB-4 score of 1.45-3.25, hospitalization rate/1,000-person-years was 41.4 among HCV+ and 20.2 among HCV-, while among those with a FIB-4>3.25, the rate- was 9.4 and 0.6 (P<0.0001). There was no difference in all-cause mortality by age, sex, FIB-4 score, number of comorbidities or treatment with remdesivir and/or systemic corticosteroids.
Conclusions: HCV+ persons with SARS-CoV-2 infection are more likely to be admitted to a hospital. The hospitalization rate also increased with higher FIB-4 score. However, admission to an ICU and mortality are not different between those with and without HCV infection.